InsidersTradesSigma
Track the Kinnate Biopharma Inc. share price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, Kinnate Biopharma Inc. has published 42 reports. The latest transaction was reported on 5 April 2024 (Disposition). Among the most active insiders: Krishnamohan Neha. All data is free.
42
Insider Decl.
n/a
Thresholds
€12m
9 ops.
Buy Volume
n/a
8 ops.
Sell Volume
43Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 April 2024
Declarations42 total
9,671,643 sharesCommon StockSEC:0001104659-24-044187:0
2,186 sharesCommon StockSEC:0001415889-24-010433:0
1,368,339 sharesCommon StockSEC:0000947871-24-000353:0
64,087 sharesCommon StockSEC:0001415889-24-010431:0
1,368,339 sharesCommon StockSEC:0000947871-24-000354:0
27,578 sharesCommon StockSEC:0001415889-24-010424:0
66,377 sharesCommon StockSEC:0001415889-24-010428:0
9,671,643 sharesCommon StockSEC:0001415889-24-010434:0
1,506 shares@ US$2.5910.3% of flowCommon StockSEC:0001415889-24-006755:0
558 shares@ US$2.591.0% of flowCommon StockSEC:0001415889-24-006754:0
558 shares@ US$2.5910.3% of flowCommon StockSEC:0001415889-24-006753:0
1,459 shares@ US$2.258.6% of flowCommon StockSEC:0001209191-23-057455:0
541 shares@ US$2.250.9% of flowCommon StockSEC:0001209191-23-057457:0
541 shares@ US$2.258.6% of flowCommon StockSEC:0001209191-23-057454:0
1,459 shares@ US$2.359.0% of flowCommon StockSEC:0001209191-23-048429:0
541 shares@ US$2.350.9% of flowCommon StockSEC:0001209191-23-048424:0
541 shares@ US$2.359.1% of flowCommon StockSEC:0001209191-23-048426:0
541 shares@ US$4.301.7% of flowCommon StockSEC:0001209191-23-034445:0
541 shares@ US$4.3016.7% of flowCommon StockSEC:0001209191-23-034444:0
1,459 shares@ US$4.3016.7% of flowCommon StockSEC:0001209191-23-034447:0
1,550,956 shares@ US$2.80100.0% of flowCommon StockSEC:0001209191-23-028537:0
Canonical exit: 6 Aug 2023 (T+90)
1,550,956 shares@ US$2.80100.0% of flowCommon StockSEC:0001209191-23-028527:0
Canonical exit: 6 Aug 2023 (T+90)
83,459 shares@ US$2.7511.9% of flowCommon StockSEC:0000947871-23-000540:0
Canonical exit: 2 Aug 2023 (T+90)
83,459 shares@ US$2.7511.9% of flowCommon StockSEC:0000947871-23-000541:0
Canonical exit: 2 Aug 2023 (T+90)
60,998 shares@ US$2.558.1% of flowCommon StockSEC:0000947871-23-000516:0
Canonical exit: 27 Jul 2023 (T+90)
25 of 42 declarations
Acerca de Kinnate Biopharma Inc.
Kinnate Biopharma Inc. es una empresa biofarmacéutica centrada en el desarrollo de terapias dirigidas para el cáncer. Emplea enfoques innovadores para identificar y desarrollar fármacos que aborden necesidades médicas no satisfechas.